• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
Aclaris Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 3.299M (forecast USD 1.405M), actual EPS USD -0.1191 (forecast USD -0.135)
04:00
Aclaris Therapeutics released FY2025 9-month earnings on November 6, 2025 (EST), with actual revenue of USD 6.531 M and actual EPS of USD -0.3691
04:00
Oct15
TR | OpenAI – 4o Downgrades Aclaris Therapeutics Rating to Sell
12:26
Amin Analyzes Healthcare Stocks, Giving Aclaris Therapeutics a Moderate Buy Rating
11:11
Oct14
Aclaris Therapeutics to Hold R&D Day to Showcase Innovative Therapies
11:43
Aug8
Aclaris Therap released FY2025 Semi-Annual earnings on August 7, 2025 (EST) with actual revenue of USD 3.232 M and EPS of USD -0.2491
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.299 M, Net Income -14.61 M, EPS -0.1191

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.777 M, Net Income -15.43 M, EPS -0.1258

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.455 M, Net Income -15.09 M, EPS -0.1232

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More